|
AIDA expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.281890E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.605600E-02 |
| Normal-vs-Stage2 |
2.668600E-01 |
| Normal-vs-Stage3 |
2.760100E-03 |
| Normal-vs-Stage4 |
9.039800E-04 |
| Stage1-vs-Stage2 |
6.304800E-03 |
| Stage1-vs-Stage3 |
8.030000E-02 |
| Stage1-vs-Stage4 |
1.522230E-02 |
| Stage2-vs-Stage3 |
6.637600E-04 |
| Stage2-vs-Stage4 |
1.421250E-04 |
| Stage3-vs-Stage4 |
3.639400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.015300E-03 |
| Normal-vs-AfricanAmerican |
3.467400E-01 |
| Normal-vs-Asian |
1.955700E-02 |
| Caucasian-vs-AfricanAmerican |
8.663200E-01 |
| Caucasian-vs-Asian |
5.976000E-01 |
| AfricanAmerican-vs-Asian |
6.727400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.921100E-03 |
| Normal-vs-Female |
3.073900E-02 |
| Male-vs-Female |
2.999800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.744000E-02 |
| Normal-vs-Age(41-60Yrs) |
3.278300E-02 |
| Normal-vs-Age(61-80Yrs) |
7.054500E-02 |
| Normal-vs-Age(81-100Yrs) |
5.337600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.775200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.095200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.595600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.654400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.380200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.686600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.335350E-03 |
| Classical-VS-Follicular |
3.51980000701246E-10 |
| Classical-VS-Other |
9.786400E-01 |
| Classical-VS-Normal |
4.967500E-04 |
| Tall-VS-Follicular |
3.17480042255625E-10 |
| Tall-VS-Other |
1.284580E-01 |
| Tall-VS-Normal |
1.71709999996494E-07 |
| Follicular-VS-Other |
4.059700E-02 |
| Follicular-VS-Normal |
2.156300E-02 |
| Other-VS-Normal |
1.737780E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.540200E-01 |
| Normal-vs-N1 |
1.410410E-02 |
| N0-vs-N1 |
1.083890E-02 |
|
|
